@article{1fbcde62654f460c96dce214534fe579,
title = "Presence of Comorbidities and Use of Concomitant Medications Associated with QTC Prolongation/torsades de pointes in Patients with HR+/HER2- advanced Breast Cancer",
abstract = " K. Lewis; E. Clayton; M. Last; D. Mitra; S.K. Kurosky ",
author = "Reshma Mahtani",
note = "Abstract. BACKGROUND: Corrected QT (QTc) prolongation is a cardiac condition that may increase the risk of ventricular arrhythmias, including Torsades de Pointes (TdP), and cardiac-related death. QTc prolongation is a notable concern in oncology as drug-induced QTc prolongation is a documented side effect of several anticancer therapies.",
year = "2021",
month = feb,
day = "15",
language = "American English",
volume = "81",
journal = "Cancer Research / San Antonio Breast Cancer Symposium",
}